ITGB2 and neoplasm: According to Zu et al. [87], Itgb2 also corresponds to a negative regulator of tumor cell proliferation and a positive regulator of E-cadherin expression, with a lower expression level reported in non-small cell lung cancer (NSCLC) tumor tissues than in physiological tissues.